Newsroom

Glenmark Pharmaceuticals receives ANDA approval for Tretinoin Capsules, 10 mg

27 Dec 2016 | Read More

Glenmark Unveils its Strategic Blueprint for Transition into an Innovation‐Led Global Pharmaceutical Organization in the Next Decade

19 Dec 2016 | Read More

Glenmark Launches First and Only Generic Version of Zetia® in the United States

12 Dec 2016 | Read More

Glenmark announces Pre-Clinical Data Results for experimental GBR 1302-Beat Technology

4 Nov 2016 | Read More

Glenmark announces Strategic Development and Global Licensing Agreement with Particle Sciences

19 Sep 2016 | Read More

Glenmark Pharmaceuticals receives ANDA approval for Diclofenac Sodium Gel, 3%

14 Sep 2016 | Read More

Glenmark Pharmaceuticals receives ANDA approval for Lidocaine Ointment USP, 5%

12 Sep 2016 | Read More

Glenmark announces the Discovery and Initiation of IND‐enabling studies of a novel Bispecific Monoclonal Antibody targeting EGFR

6 Sep 2016 | Read More

Glenmark’s consolidated revenue increased by 18% for Q1 FY 2016 – 17

12 Aug 2016 | Read More

ANDA approval for  Potassium Chloride Extended-Release Tablets

27 Jul 2016 | Read More

ANDA approval of Rosuvastatin Calcium Tablets

20 Jul 2016 | Read More

Glenmark Pharmaceuticals receives tentative ANDA approval for  Olmesartan Medoxomil Tablets, 5 mg, 20 mg and 40 mg.

24 Jun 2016 | Read More

Glenmark Pharmaceuticals receives ANDA approval for  Nystatin and Triamcinolone Acetonide Ointment USP,  100,000 units/1 mg per gram.

24 Jun 2016 | Read More

Glenmark Pharmaceuticals receives ANDA approval for  Rufinamide Tablets USP, 200 mg and 400 mg.

19 May 2016 | Read More

Glenmark’s Consolidated Revenue for Q4 FY 2015 – 16 was at Rs. 23066.76 Mn recording an increase of 29.89%.

12 May 2016 | Read More

Glenmark Pharmaceuticals receives tentative ANDA approval for Adapalene and Benzoyl Peroxide Gel.

29 Apr 2016 | Read More

Glenmark Pharmaceuticals receives tentative ANDA approval for Norethindrone Acetate and Ethinyl Estradiol Tablets.

26 Apr 2016 | Read More

Glenmark Pharmaceuticals receives another two ANDA approvals from the U.S. FDA.

28 Mar 2016 | Read More

Glenmark Pharmaceuticals receives ANDA approval for Bendamustine Hydrochloride for Injection.

28 Mar 2016 | Read More

Glenmark Pharmaceuticals receives ANDA approval for Raloxifene Hydrochloride Tablets.

23 Mar 2016 | Read More

Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Oral Solution, 10 mg/mL

18 Mar 2016 | Read More

Glenmark Pharmaceuticals receives ANDA approval for Frovatriptan Succinate Tablets.

14 Mar 2016 | Read More

Glenmark Pharmaceuticals receives ANDA approval for Norgestimate and Ethinyl Estradiol Tablets.

24 Feb 2016 | Read More

Glenmark Pharmaceuticals receives tentative ANDA approval for Azelaic Acid Gel.

17 Feb 2016 | Read More

Glenmark’s Consolidated Net Profit increases by 48.38% to Rs. 1703 Mn in Q3 FY 15-16

28 Jan 2016 | Read More

Glenmark Pharmaceuticals receives ANDA approval for Norethindrone Acetate and Ethinyl Estradiol Tablets.

21 Jan 2016 | Read More

Glenmark Pharmaceuticals receives ANDA approval for Potassium Chloride Extended-Release Capsules.

21 Jan 2016 | Read More

Glenmark announces the Discovery and Initiation of IND‐enabling studies of a novel bi‐specific monoclonal antibody targeting CD38.

8 Jan 2016 | Read More

Glenmark Pharmaceuticals Inc., USA receives tentative ANDA approval for Dronedarone Tablets.

6 Jan 2016 | Read More

Library

Profile – Chairman and Managing Director
+
Profile – Chairman and Managing Director
With the idea of creating something unique, Glenn Saldanha took over the reins of the company and helped transform it into a global enterprise worth USD 1.1 billion with offices across 20 countries. Download Profile
Profile – Glenmark Pharmaceuticals
+
Profile – Glenmark Pharmaceuticals
Research-driven, global and integrated pharmaceutical company which is driven to meet unmet medical needs and help pave a new way for a new world. Download Profile

For any media related queries, please email corpcomm@glenmarkpharma.com